| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/05/2008 | US20080132523 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/05/2008 | US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
| 06/05/2008 | US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/05/2008 | CA2670704A1 New process for remifentanil synthesis |
| 06/04/2008 | EP1927587A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 06/04/2008 | EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/04/2008 | EP1828131B1 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 06/04/2008 | EP1747198B1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | CN101193852A Analogs of 4-hydroxyisoleucine and uses thereof |
| 06/04/2008 | CN101190915A Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application |
| 06/04/2008 | CN101190914A 16-site substituted double functional group huperzine B derivative, preparation method and use thereof |
| 06/04/2008 | CN100391946C Method for preparing amlodipine benzenesulfonate |
| 06/04/2008 | CN100391942C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments |
| 06/03/2008 | US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/03/2008 | US7381735 Ultrashort-acting opioids for transdermal application |
| 06/03/2008 | US7381734 Serine protease inhibitors |
| 06/03/2008 | US7381721 Substituted piperidine compounds |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2350473C Method for producing optically active .alpha.-aminonitriles and .alpha.-amino acids |
| 05/29/2008 | WO2008062252A1 N-oxides of cytotoxic anthraquinones as hypoxia-targeting prodrugs in cancer treatment |
| 05/29/2008 | WO2008045564A3 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 05/29/2008 | WO2007147604A3 Aqueous, alkaline bath, devoid of cyanide, for depositing electroplated zinc alloy coatings |
| 05/29/2008 | WO2007072150A3 Piperidine derivatives |
| 05/29/2008 | US20080125468 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125442 Cathepsin K Inhibitors and Atherosclerosis |
| 05/29/2008 | US20080125430 New small molecule inhibitors of mdm2 and the uses thereof |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/28/2008 | EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1768954A4 2-methylpropanamides and their use as pharmaceuticals |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | CN101189226A Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists |
| 05/28/2008 | CN101189013A Crystalline (2E,4S)-4-[(N-{[(2R)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-L-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and its pharmaceutical uses |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN100390146C Process for making risperidone and intermediates therefor |
| 05/28/2008 | CN100390145C Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-a, a-dimethylbenzene acetic acid and its hydrochloride |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378527 Process for the preparation of torsemide and related intermediates |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378440 Antidiabetic agents; therapy for insulin resistance |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378425 For preventing, treating and/or improving a disease against which a sigma receptor binding action and/or an acetylcholinesterase inhibitory action is efficacious |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008060999A1 Piperidinyl arylsulfone derivatives as modulators of secreted frizzled related protein-1 |
| 05/22/2008 | WO2008060093A1 Crystalline s-(-)-amlodipine maleic acid salt anhydride and preparation method thereof |
| 05/22/2008 | WO2008059862A1 Method for producing optically active 2-(2'-piperidinyl)acetate |
| 05/22/2008 | WO2008059854A1 Piperidine derivatives or salts thereof |
| 05/22/2008 | WO2008059239A1 Novel compounds 514 |
| 05/22/2008 | WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| 05/22/2008 | WO2008058387A1 Renin inhibitors |
| 05/22/2008 | WO2007147770A3 Substituted phenyl methanone derivatives |
| 05/22/2008 | WO2007147605A3 Tripyridinium compounds used as additives in aqueous alkaline baths, devoid of cyanide, for the deposition of electroplated zinc and zinc alloy coatings |
| 05/22/2008 | WO2007121481A3 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 05/22/2008 | US20080119649 Halocombstatins and methods of synthesis thereof |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119478 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 05/22/2008 | US20080119459 Trifluoromethylbenzamide Derivatives and Therapeutic Uses Thereof |
| 05/22/2008 | US20080119451 N-(2-aminophenyl)-4-(3-methylpyridin-2-yl)benzamide; histone deacetylase (HDAC) and angiogenesis inhibitor; antiproliferative agent; solid tumor cancers, lymphomas, myelomas, melanomas; antiinflammatory agent; arthritis, psoriasis, multiple sclerosis, asthma |
| 05/22/2008 | US20080118560 Spray congealed 5-amido-7-benzyl(oxy or amino)imidazo[1,2-a]pyridines, at least one each of hydrophilic and hydrophobic matrix formers; antisecretory agents with improved water solubility, bioavailability and pharmacokinetics |
| 05/22/2008 | US20080118405 Bifunctional Chemical, Preparation and Use for Detecting Nucleic Acid |
| 05/22/2008 | CA2669635A1 Piperidine derivative or salt thereof |
| 05/22/2008 | CA2668742A1 Renin inhibitors |
| 05/21/2008 | EP1922305A1 New salt ii |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | CN101184733A Novel piperidine carboxylic acid amide derivatives |
| 05/21/2008 | CN101182306A Method for synthesizing intermediate of fexofenadine |
| 05/21/2008 | CN101181241A Fentanyl composition for nasal administration |
| 05/20/2008 | US7375231 Intermediate compound which is used for the preparation of pioglitazone |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375217 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375121 Chemical compounds |
| 05/20/2008 | US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375115 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 05/20/2008 | US7375105 Neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine, cardiac hypertrophy |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/15/2008 | WO2008057775A2 Heterocyclic amide compounds useful as kinase inhibitors |
| 05/15/2008 | WO2008057282A1 Calcium receptor modulating agents |
| 05/15/2008 | WO2008055851A1 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)-benzamide and salts thereof |
| 05/15/2008 | WO2007147603A3 Aqueous alkaline bath, devoid of cyanide, for the deposition of electroplated zinc and zinc alloy coatings |
| 05/15/2008 | WO2007064914A8 5-(arylsulfonyl)-pyrazolopiperidines |
| 05/15/2008 | US20080114173 Crystalline Form of Donepezil Hydrochloride |
| 05/15/2008 | US20080114168 Novel esters as useful broad spectrum herbicidal compounds |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080113995 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine; histamine-H3 receptor antagonist or inverse agonist; nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 05/15/2008 | US20080113922 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents |
| 05/15/2008 | DE19753655B4 α-Aminoacetophenonverbindungen, Massen, die diese Verbindungen enthalten und deren Verwendung als Photostarter α-Aminoacetophenonverbindungen, compositions containing these compounds and their use as photoinitiators |
| 05/15/2008 | CA2668424A1 Water tolerant emulsion stabilizers |
| 05/15/2008 | CA2660364A1 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)-benzamide and salts thereof |